Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10

Literature DB >> 33199465

Christen Shoesmith¹, Agessandro Abrahao², Tim Benstead², Marvin Chum², Nicolas Dupre², Aaron Izenberg², Wendy Johnston², Sanjay Kalra², Desmond Leddin², Colleen O'Connell², Kerri Schellenberg², Anu Tandon², Lorne Zinman².

Abstract

Year: 2020 PMID： 33199465 PMCID： PMC7683006 DOI： 10.1503/cmaj.191721-f

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

Keyword Cloud
References

× No keyword cloud information.

57 in total

1. Riluzole and other prognostic factors in ALS: a population-based registry study in Italy.

Authors: Jessica Mandrioli; Sara Angela Malerba; Ettore Beghi; Nicola Fini; Antonio Fasano; Elisabetta Zucchi; Silvia De Pasqua; Carlo Guidi; Emilio Terlizzi; Elisabetta Sette; Alessandro Ravasio; Mario Casmiro; Fabrizio Salvi; Rocco Liguori; Lucia Zinno; Yasmin Handouk; Romana Rizzi; Annamaria Borghi; Rita Rinaldi; Doriana Medici; Mario Santangelo; Enrico Granieri; Vittoria Mussuto; Marina Aiello; Salvatore Ferro; Marco Vinceti
Journal: J Neurol Date: 2018-02-05 Impact factor: 4.849

2. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.

Authors:
Journal: Lancet Neurol Date: 2017-05-15 Impact factor: 44.182

3. Multidisciplinary ALS care improves quality of life in patients with ALS.

Authors: J P Van den Berg; S Kalmijn; E Lindeman; J H Veldink; M de Visser; M M Van der Graaff; J H J Wokke; L H Van den Berg
Journal: Neurology Date: 2005-10-25 Impact factor: 9.910

4. "I hate being a burden": The patient perspective on carer burden in amyotrophic lateral sclerosis.

Authors: Geraldine Foley; Virpi Timonen; Orla Hardiman
Journal: Amyotroph Lateral Scler Frontotemporal Degener Date: 2016-02-09 Impact factor: 4.092

5. A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland.

Authors: James Rooney; Susan Byrne; Mark Heverin; Katy Tobin; Alison Dick; Colette Donaghy; Orla Hardiman
Journal: J Neurol Neurosurg Psychiatry Date: 2014-12-30 Impact factor: 10.154

6. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial.

Authors: B R Brooks; R A Thisted; S H Appel; W G Bradley; R K Olney; J E Berg; L E Pope; R A Smith
Journal: Neurology Date: 2004-10-26 Impact factor: 9.910

7. A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis.

Authors: Lora L Clawson; Merit Cudkowicz; Lisa Krivickas; Benjamin R Brooks; Mohammed Sanjak; Peggy Allred; Nazem Atassi; Amy Swartz; Gabrielle Steinhorn; Alpa Uchil; Kristen M Riley; Hong Yu; David A Schoenfeld; Nicholas J Maragakis
Journal: Amyotroph Lateral Scler Frontotemporal Degener Date: 2017-11-30 Impact factor: 4.092

8. Family caregivers' accounts of caring for a family member with motor neurone disease in Norway: a qualitative study.

Authors: Sverre Vigeland Lerum; Kari Nyheim Solbrække; Jan C Frich
Journal: BMC Palliat Care Date: 2016-02-24 Impact factor: 3.234

9. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study.

Authors: Ton Fang; Ahmad Al Khleifat; Jacques-Henri Meurgey; Ashley Jones; P Nigel Leigh; Gilbert Bensimon; Ammar Al-Chalabi
Journal: Lancet Neurol Date: 2018-03-07 Impact factor: 44.182

10. Evidence of an environmental effect on survival in ALS.

Authors: Noa Keren; Kirsten M Scott; Miho Tsuda; Jessica Barnwell; Jonathan A Knibb; Cathy M Ellis; P Nigel Leigh; Christopher E Shaw; Ammar Al-Chalabi
Journal: Amyotroph Lateral Scler Frontotemporal Degener Date: 2014-05-27 Impact factor: 4.092